Assignee
ORPHAZYME AS
DK·8 granted patents·9 pending applications·17 citations·filing 2015–2022
Top patents by PatentIndex Score
17 records- 0191US11045460B2Use of Hsp70 as a regulator of enzymatic activityORPHAZYME AS·Filed 2019·Granted Jun 29, 2021·4 cites·5 claims
- 0290US11304941B2Use of HSP70 as a regulator of enzymatic activityORPHAZYME AS·Filed 2019·Granted Apr 19, 2022·3 cites·5 claims
- 0389US10543204B2Use of Hsp70 as a regulator of enzymatic activityORPHAZYME AS·Filed 2017·Granted Jan 28, 2020·6 cites·14 claims
- 0482US10532085B2Methods for increasing intracellular activity of Hsp70ORPHAZYME AS·Filed 2017·Granted Jan 14, 2020·3 cites·11 claims
- 0576US11253505B2Arimoclomol for treating glucocerebrosidase associated disordersORPHAZYME AS·Filed 2020·Granted Feb 22, 2022·1 cites·9 claims
- 0673US2022374361A1Methods for increasing intracellular activity of hsp70ORPHAZYME AS·Filed 2022·Application pending·0 cites
- 0766US2022133707A1Arimoclomol for treating glucocerebrosidase associated disordersORPHAZYME AS·Filed 2022·Application pending·0 cites
- 0859US2019111041A1Arimoclomol for treating glucocerebrosidase associated disordersORPHAZYME AS·Filed 2017·Application pending·0 cites
- 0953US11229633B2Arimoclomol formulationORPHAZYME AS·Filed 2020·Granted Jan 25, 2022·0 cites·16 claims
- 1053US2023226036A1Arimoclomol for treating gaucher diseaseORPHAZYME AS·Filed 2021·Application pending·0 cites
- 1151US10898476B2Heat shock proteins and cholesterol homeostasisORPHAZYME AS·Filed 2017·Granted Jan 26, 2021·0 cites·12 claims
- 1250US2021186949A1Heat shock proteins and cholesterol homeostasisORPHAZYME AS·Filed 2020·Application pending·0 cites
- 1349US2020188492A1Methods for increasing intracellular activity of hsp70ORPHAZYME AS·Filed 2019·Application pending·0 cites
- 1448US10709700B2Arimoclomol formulationORPHAZYME AS·Filed 2015·Granted Jul 14, 2020·0 cites·15 claims
- 1547US2022211687A1Use of arimoclomol in the treatment of niemann pick diseaseORPHAZYME AS·Filed 2021·Application pending·0 cites
- 1646US2021164997A1Hsp70 protein levels in pbmc samples as biomarker for diseaseORPHAZYME AS·Filed 2019·Application pending·0 cites
- 1738US2020085812A1Heat shock protein inducers and frontotemporal disordersORPHAZYME AS·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →